Ulcerative colitis: Which makes patients happier, surgery or anti-TNF therapy?

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 5, 2014, Pages 272-273

  Kobayashi, Taku ^a   Hibi, Toshifumi ^a  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; TUMOR NECROSIS FACTOR ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; ATTITUDE TO ILLNESS; COST EFFECTIVENESS ANALYSIS; DIGESTIVE TRACT PARAMETERS; DISABILITY INDEX FOR INFLAMMATORY BOWEL DISEASE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT DECISION MAKING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; PUBLIC HEALTH INSURANCE; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; STOOL FREQUENCY; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; COLOSTOMY BAG; FEMALE; MALE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; HUMANS; MALE; PROCTOCOLECTOMY, RESTORATIVE; QUALITY OF LIFE;

EID: 84900429133     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.28     Document Type: Article

References (10)

1. Meijs, S. et al. Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. J. Crohns Colitis http://dx.doi.org/10.1016/j. crohns.2013.12.011.
2. Oussalah, A. et al. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am. J. Gastroenterol. 105, 2617-2625 (2010).
3. Francone, T. D. & Champagne, B. Considerations and complications in patients undergoing ileal pouch anal anastomosis. Surg. Clin. North Am. 93, 107-143.
4. Casellas, F. et al. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFa treatment. J. Crohns Colitis 6, 881-886 (2012).
5. Feagan, B. G. et al. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am. J. Gastroenterol. 102, 794-802 (2007).
6. Heikens, J. T. et al. Quality of life and health status before and after ileal pouch-anal anastomosis for ulcerative colitis. Br. J. Surg. 99, 263-269 (2012).
7. Cohen, R. D., Brodsky, A. L. & Hanauer, S. B. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm. Bowel Dis. 5, 1-10 (1999).
8. Park, K. T. et al. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann. Surg. 256, 117-124 (2012).
9. Steenholdt, C. et al. Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study. Scand. J. Gastroenterol. 47, 518-527 (2012).
10. Peyrin-Biroulet, L. et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61, 241-247 (2011).